Company officials said Monday they are not pursuing a merger with rival Humana, causing Cigna's stock to rise in the markets.

Wells Fargo raised the firm’s price target on Cigna (CI) to $370 from $355 and keeps an Equal Weight rating on the shares as the firm updates ...

The courtship between insurance giants Cigna and Humana is just not meant to be, Cigna officials said Monday. Why it matters: ...

Wells Fargo analyst Steve Baxter maintained a Hold rating on Cigna (CI – Research Report) today and set a price target of $370.00. The ...

Despite reports that merger talks were back on, Cigna officially squashed rumors that it was looking to acquire Humana in a ...

The two health insurance giants held talks about a deal last year, but Cigna walked away after the two companies failed to ...

Cigna stated clearly in its release today that it is "not pursuing a combination with Humana." Investors had been wondering ...

A Humana/Cigna merger would have combined Cigna’s commercial insurance and pharmacy-benefit businesses with Humana’s Medicare ...

There are dermatologists who don’t have much training in vulvar dermatology, and a lot of gyns don’t get as much training” as ...

In recent years, the Nigeria’s healthcare landscape has been challenged by a significant brain drain, with many of the ...

Cigna Group is not pursuing a combination with rival Humana, the health insurer said on Monday, days after Donald Trump's ...

The flat-out denial comes after Cigna CEO David Cordani tried to discourage persistent speculation of a Humana merger earlier ...